TGM2 and cancer: Since TG2 is already looked at as a potential therapeutic target in cancer (33, 76) as its expression promotes chemo/radioresistance and invasive functions by inducing mesenchymal transition, a more in-depth understanding of the interplay of these two molecules in the therapeutic perspective, would be important to investigate.